Completed NA INTERVENTIONAL 2-arm NCT01656967

AMBU AScope2 Fiberoptic Intubation Versus Fastrach Intubating LMA

Flexible Optical Intubation Via the AMBU Aura-I Versus Blind Intubation Via the Fastrach Single Use Intubating LMA - A Prospective Randomized Clinical Trial

Sponsor: Ambu A/S

Conditions Supraglottic Airway

Interventions AMBU Aura-I/aScope 2 LMA Fastrach Single Use

Updated 9 times since 2017 Last updated: Oct 10, 2018 Started: Jul 31, 2010 Primary completion: Jan 31, 2013 Completion: Jan 31, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Supraglottic Airway, this trial is completed. The trial is conducted by Ambu A/S and has accumulated 9 data snapshots since 2010. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

9 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Dec 2021 — Jul 2024 [monthly]

Completed NA
Jan 2021 — Dec 2021 [monthly]

Completed NA
Dec 2018 — Jan 2021 [monthly]

Completed NA

▶ Show 4 earlier versions

Jun 2018 — Dec 2018 [monthly]

Completed NA
Jul 2017 — Jun 2018 [monthly]

Completed NA
Feb 2017 — Jul 2017 [monthly]

Completed NA
Jan 2017 — Feb 2017 [monthly]

Completed NA

First recorded

Jul 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Ambu A/S
The University of Texas Health Science Center, Houston

Data source: The University of Texas Health Science Center, Houston

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Houston, United States